References
- Chen C, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson Igor B. 1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 47(3):381–389.10.1016/0092-8674(86)90595-7
- Dewanjee S, Dua TK, Bhattacharjee N, Das A, Gangopadhyay M, Khanra R, Joardar S, Riaz M, Feo V, Zia-Ul-Haq M. 2017. Natural products as alternative choices for P-glycoprotein (P-gp) inhibition. Molecules. 22(6):871–963.10.3390/molecules22060871
- Karthikeyan S, Hoti SL. 2015. Development of fourth generation ABC inhibitors from natural products: a novel approach to overcome cancer multidrug resistance. Anticancer Agents Med Chem. 15(5):605–615.10.2174/1871520615666150113103439
- Li P, Deng YP, Wei XX, Xu JH. 2013. Triterpenoids from ganoderma lucidum and their cytotoxic activities. Nat Prod Res. 27(1):17–22.10.1080/14786419.2011.652961
- Ozben T. 2006. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 580(12):2903–2909.10.1016/j.febslet.2006.02.020
- Shi YQ, Qu XJ, Liao YX, Xie CF, Cheng YN, Li S, Lou HX. 2008. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Eur J Pharmacol. 584(1):66–71.10.1016/j.ejphar.2008.01.039
- Silverman JA, Deitcher SR. 2013. Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemoth Pharm. 71(3):555–564.10.1007/s00280-012-2042-4
- Xiang QF, Zhang DM, Wang JN, Zhang HW, Zheng ZY, Yu DC, Li YJ, Xu J, Chen YJ, Shang CZ. 2015. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein. Liver Int. 35(3):1010–1023.10.1111/liv.2015.35.issue-3